SCHEMBL1927738

SCHEMBL1927738

CCOC(=O)C(C)Oc1cc(C)c(C)c(C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
LMNA P02545 1/20 0.50
TDP1 Q9NUW8 3/20 0.46
EPHX2 P34913 2/20 0.44
ALDH1A1 P00352 6/20 0.44
KDM4E B2RXH2 4/20 0.44
HPGD P15428 2/20 0.44
SMN1; SMN2 Q16637 4/20 0.43
POLB P06746 1/20 0.43
ALDH2 P05091 2/20 0.41
IDH1 O75874 1/20 0.41
TSHR P16473 4/20 0.40
MAPK1 P28482 3/20 0.40
MAPT P10636 2/20 0.40
ALOX15 P16050 2/20 0.40
HSD17B10 Q99714 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MEN1 O00255 1/20 0.40
GAA P10253 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1928235 0.86 ALDH1A1 (0.53) KMT2AL3MBTL1LMNATDP1EPHX2
SCHEMBL5209931 0.84 TDP1 (0.67) KMT2AL3MBTL1LMNATDP1EPHX2
SCHEMBL1928099 0.82 LMNA (0.45) KMT2AL3MBTL1LMNATDP1EPHX2
SCHEMBL31274977 0.80 L3MBTL1 (0.52) KMT2AL3MBTL1LMNATDP1EPHX2
SCHEMBL2872775 0.80 L3MBTL1 (0.52) KMT2AL3MBTL1LMNATDP1EPHX2
SCHEMBL1927200 0.79 TDP1 (0.70) KMT2ATDP1ALDH1A1KDM4EHPGD
SCHEMBL1927735 0.78 SMN1; SMN2 (0.40) KMT2AL3MBTL1LMNATDP1ALDH1A1
SCHEMBL22542311 0.78 LMNA (0.57) KMT2AL3MBTL1LMNATDP1EPHX2
SCHEMBL10933587 0.77 IDH1 (0.47) KMT2AL3MBTL1LMNAEPHX2ALDH1A1
SCHEMBL28738504 0.77 KMT2A (0.50) KMT2AL3MBTL1LMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7956188-B2 N-substituted-2-alkylthio-2-(substituted aryloxy and heteroaryloxy)alkylamides and their sulphinyl and sulphonyl derivatives such as 2-(3,5-dichlorophenoxy)-2-methylthio-N-2-methylprop-2-yl acetamide; fungal infections of plants SYNGENTA CROP PROTECTION, INC. (US) 2011-06-07 US disclosed
EP-1817309-B1 ACETAMIDE COMPOUNDS AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2009-12-23 EP disclosed
US-20080171767-A1 N-substituted-2-alkylthio-2-(substituted aryloxy and heteroaryloxy)alkylamides and their sulphinyl and sulphonyl derivatives such as 2-(3,5-dichlorophenoxy)-2-methylthio-N-2-methylprop-2-yl acetamide; fungal infections of plants SYNGENTA CROP PROTECTION, INC. (US) 2008-07-17 US disclosed
EP-1817309-A1 ACETAMIDE COMPOUNDS AS FUNGICIDES Syngeta Participations AG (CH) 2007-08-15 EP disclosed
WO-2006058700-A1 ACETAMIDE COMPOUNDS AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080171767-A1 N-substituted-2-alkylthio-2-(substituted aryloxy and heteroaryloxy)alkylamides and their sulphinyl and sulphonyl derivatives such as 2-(3,5-dichlorophenoxy)-2-methylthio-N-2-methylprop-2-yl acetamide; fungal infections of plants NAT1, DPM1, AADAC KMT2A 66/4885L3MBTL1 960/4885LMNA 4617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.